Jennifer Caswell-Jin

@caswell_jin

Breast oncology, cancer genetics & genomics

Vrijeme pridruživanja: ožujak 2018.

Tweetovi

Blokirali ste korisnika/cu @caswell_jin

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @caswell_jin

  1. 27. sij

    This tweetstory is beautiful and reminds me of a great course I took in college by Prof Kuriyama who wrote The Expressiveness of the Body. How we have viewed the functions of the body throughout history and today is weighted with meaning, insight, and creative genius.

    Poništi
  2. 25. sij

    Gives me hope that pancytopenia from marrow involvement in breast cancer (which can make it hard to use our most effective drugs) could be similarly targetable, improving options and outcomes.

    Prikaži ovu nit
    Poništi
  3. 25. sij

    The amazing giving an amazing talk on her work on bone marrow failure in AML at . It is not caused by blasts crowding out the marrow, and its mechanisms are targetable!

    Prikaži ovu nit
    Poništi
  4. proslijedio/la je Tweet
    21. sij

    Our lab is growing! Interested in multi-modal/spatial single-cell analysis? We are seeking applications for experimental and computational staff scientists until 2/15, and are always recruiting postdocs. More info at . Just DM me a CV to apply, please RT!

    Poništi
  5. 9. sij

    was an incredible, career-defining experience. And I am one of those people who used Dr Prowell's tips 😀

    Poništi
  6. 31. pro 2019.

    This thread is inspiring me to recertify for IM (in 3 years...we will see if the inspiration holds) and see what else my own time jump may reveal. The cystic fibrosis advances since my residency are the most stunning to me.

    Poništi
  7. 13. pro 2019.
    Poništi
  8. 13. pro 2019.

    Visit me at my poster! P4-07-01. If I am not here I may have been tempted away by some of the awesome posters at this session so tweet at me :)

    Poništi
  9. 12. pro 2019.

    Also I want to admit: before the neg results on atezo today, I was considering trialing pembro/carbo/taxane in a pt with very high risk disease who is hesitant about anthracyclines. Today reminds me why going outside what was actually studied in the trial can be dangerous.

    Prikaži ovu nit
    Poništi
  10. 12. pro 2019.

    Ha Dr Kalinsky’s slide came up right after I tweeted this. I need to wait a minute and let the discussant present

    Prikaži ovu nit
    Poništi
  11. 12. pro 2019.

    Much to ponder in the differences between these trials.. Anthracyclines? Could PD-L1 (durvalumab and atezolizumab) vs PD-1 (pembrolizumab) matter in early stage disease? It’s never simple..

    Prikaži ovu nit
    Poništi
  12. 12. pro 2019.

    Excellent summary of fascinating work. Still at that stage of twitter where I retweet so I can find things again, but worth reading if you haven’t seen yet.

    Poništi
  13. 11. pro 2019.

    Fascinating to see the rebirth of an old idea, and perhaps a paradigm shift for my generation. We grew up thinking about AR inhibitors for AR-positive tumors, so I wondered why aromatase inhibitors (which may increase androgens locally in theory) worked so well..!

    Poništi
  14. proslijedio/la je Tweet
    15. lis 2019.

    Major gaps in clinician communication about genetic testing in our new study. DOI: 10.1200/JOP.19.00221

    Prikaži ovu nit
    Poništi
  15. proslijedio/la je Tweet
    20. ruj 2019.

    We at are looking for a GI Leader. Please retweet and DM me if interested.

    Poništi
  16. proslijedio/la je Tweet
    15. kol 2019.

    Ludwig ’s Tian Yi Zhang thinks the future of personalized medicine depends on our ability to match treatments with patients’ unique genetic markers.

    Prikaži ovu nit
    Poništi
  17. 23. kol 2019.
    Poništi
  18. 22. kol 2019.
    Poništi
  19. proslijedio/la je Tweet
    31. srp 2019.

    A great workshop and an amazing team!!

    Poništi
  20. proslijedio/la je Tweet
    30. srp 2019.

    Bonding at with the amazing PDG 1 Team. So proud of all of you! Thank you

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·